AAAAAA

   
Results: 1-8 |
Results: 8
CHANGES IN HEMOSTATIC AND FIBRINOLYTIC PARAMETERS IN CHILDREN WITH ALL RECEIVING L-ASPARAGINASE-(L-ASE) THERAPY
Authors: SCHOBESS R EXADAKTYLOS P REISS T LAUTENSCHLAGER C
Citation: R. Schobess et al., CHANGES IN HEMOSTATIC AND FIBRINOLYTIC PARAMETERS IN CHILDREN WITH ALL RECEIVING L-ASPARAGINASE-(L-ASE) THERAPY, Thrombosis and haemostasis, 1997, pp. 514-514
IMPROVED SURVIVAL FOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN INFANCY - THE EXPERIENCE WITH 2 MODIFIED BFM-PROTOCOLS IN EAST-GERMAN STATES
Authors: ZINTL F SCHILLER I DOMULA W DORFFEL W EGGERS G EXADAKTYLOS P KOTTE W KRAUSE I MITTLER U REDDEMANN H SIEGERT E WEINMANN W
Citation: F. Zintl et al., IMPROVED SURVIVAL FOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN INFANCY - THE EXPERIENCE WITH 2 MODIFIED BFM-PROTOCOLS IN EAST-GERMAN STATES, Blood, 90(10), 1997, pp. 319-319
PRIAPISM - A RARE MANIFESTATION OF APC-RESISTANCE IN CHILDREN
Authors: SCHOBESS R FRANKE D LUTZE G EXADAKTYLOS P REISS T SCHNEPPENHEIM R
Citation: R. Schobess et al., PRIAPISM - A RARE MANIFESTATION OF APC-RESISTANCE IN CHILDREN, Thrombosis and haemostasis, 73(6), 1995, pp. 1125-1125
CLASSIFICATION OF THE VON-WILLEBRAND-SYNDROME
Authors: SCHOBESS R BUDDE U EXADAKTYLOS P REISS T
Citation: R. Schobess et al., CLASSIFICATION OF THE VON-WILLEBRAND-SYNDROME, Thrombosis and haemostasis, 73(6), 1995, pp. 1170-1170
THE ACUTE HEPATOTOXICITY OF INTERMEDIATE- DOSE MTX IN CHILDREN WITH ACUTE-LEUKEMIA AND NON-HODGKIN-LYMPHOMA
Authors: EXADAKTYLOS P REISS T SCHOBESS R HOMMANN M HOHNE S BECK A
Citation: P. Exadaktylos et al., THE ACUTE HEPATOTOXICITY OF INTERMEDIATE- DOSE MTX IN CHILDREN WITH ACUTE-LEUKEMIA AND NON-HODGKIN-LYMPHOMA, Klinische Padiatrie, 206(4), 1994, pp. 315-318
24 MONTHS VERSUS 18 MONTHS PLUS LATE REINDUCTION TREATMENT DURATION IN A RANDOMIZED BFM ADOPTED STUDY FOR ALL THERAPY IN CHILDHOOD
Authors: ZINTL F MALKE H REIMANN M DOMULA M DORFFEL W EGGERS G EXADAKTYLOS P HILGENFELD E KOTTE W KRAUSE I MITTLER U MOBIUS D REDDEMANN H WEINMANN G
Citation: F. Zintl et al., 24 MONTHS VERSUS 18 MONTHS PLUS LATE REINDUCTION TREATMENT DURATION IN A RANDOMIZED BFM ADOPTED STUDY FOR ALL THERAPY IN CHILDHOOD, Blood, 84(10), 1994, pp. 10000145-10000145
MODIFIED BFM TREATMENT IN 91 CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND MEDIASTINAL MASS IN MULTICENTER STUDY IN EAST-GERMAN STATES
Authors: ZINTL F MALKE H REIMANN M DOMULA M DORFFEL W EGGERS G EXADAKTYLOS P HILGENFELD E KOTTE W KRAUSE I MITTLER U MOBIUS D REDDEMANN H WEINMANN G
Citation: F. Zintl et al., MODIFIED BFM TREATMENT IN 91 CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND MEDIASTINAL MASS IN MULTICENTER STUDY IN EAST-GERMAN STATES, Blood, 84(10), 1994, pp. 10000303-10000303
RESULTS AND EXPERIENCE WITH A MODIFIED BF M-PROTOCOL FOR THE TREATMENT OF RELAPSED CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN EAST-GERMANY
Authors: SAUERBREY A ZINTL F MALKE H REIMANN M MAASER M DOMULA M DORFFEL W EGGERS G EXADAKTYLOS P KOTTE W KRAUSE I MITTLER U MOBIUS D REDDEMANN H WEISSBACH G WEINMANN G
Citation: A. Sauerbrey et al., RESULTS AND EXPERIENCE WITH A MODIFIED BF M-PROTOCOL FOR THE TREATMENT OF RELAPSED CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN EAST-GERMANY, Klinische Padiatrie, 205(4), 1993, pp. 281-287
Risultati: 1-8 |